Evidence map›Paper›PMID 26404840›Full record

ArticleScience (New York, N.Y.)2015

The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.

Chanhee Kang, Qikai Xu, Timothy D Martin, Mamie Z Li, Marco Demaria, Liviu Aron, Tao Lu, Bruce A Yankner, Judith Campisi, Stephen J Elledge

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 555 papers.

0numbers the graph read from it
0cells of the map it votes in
555citing papers in PubMed
36.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

555 citing papers in PubMed, 962 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Angiogenesis in Lung Regeneration and Aging.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. APOE4 disrupts the central dogma by arresting neuronal proteome dynamics.bioRxiv : the preprint server for biology · 2026
    Article
  12. Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in AβJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

495 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chanhee KangDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA 02115, USA.
Qikai XuDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA 02115, USA.
Timothy D MartinDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA 02115, USA.
Mamie Z LiDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA 02115, USA.
Marco DemariaBuck Institute for Research on Aging, Novato, CA 94945, USA.
Liviu AronDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Tao LuDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Bruce A YanknerDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Judith CampisiBuck Institute for Research on Aging, Novato, CA 94945, USA.
Stephen J ElledgeDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA 02115, USA. selledge@genetics.med.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USBuck Institute for Research on Aging · USHoward Hughes Medical Institute · US

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
CELLULAR SENESCENCE AND CONTROL OF GENE EXPRESSIONR37AG009909 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CAMPISI, JUDITH · 1995 to 2015
$7.6M
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease (ADMINISTRATIVE SUPPLEMENT- SAGE)R01AG046174 · NIA · HARVARD MEDICAL SCHOOL · PI TSAI, LI-HUEI, YANKNER, BRUCE A · 2014 to 2018
$4.9M
Genetics of Cell Cycle &DNA Damage Regulation in YeastR37GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 2003 to 2012
$3.5M
Modeling the Aging EpigenomeDP1AG044161 · NIA · HARVARD MEDICAL SCHOOL · PI YANKNER, BRUCE A · 2012 to 2014
$2.5M
Genome Engineering an IPSC Model of Alzheimer's DiseaseRF1AG048056 · NIA · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M, YANKNER, BRUCE A · 2014 to 2014
$2.1M
GENETICS OF CELL CYCLE &DNA DAMAGE REGULATION IN YEASTR01GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 1990 to 2016
$2.0M
Modeling the Aging EpigenomeDP1OD006849 · OD · HARVARD MEDICAL SCHOOL · PI YANKNER, BRUCE A · 2010 to 2011
$1.7M
Cellular senescence and control of gene expressionR56AG009909 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI CAMPISI, JUDITH · 2017 to 2017
$592k
CELLULAR SENESCENCE AND CONTROL OF GENE EXPRESSIONR01AG009909 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI CAMPISI, JUDITH · 1990 to 1994
–
Howard Hughes Medical InstituteNIA NIH HHS AG009909NIA NIH HHS AG017242NIA NIH HHS AG046174NIA NIH HHS DP1 AG044161NIA NIH HHS P01 AG017242NIA NIH HHS R01 AG046174NIA NIH HHS R37 AG009909NIA NIH HHS R56 AG009909NIA NIH HHS RF1 AG048056NIGMS NIH HHS GM44664NIGMS NIH HHS R01 GM044664NIGMS NIH HHS R37 GM044664NIH HHS DP1 OD006849NIH HHS DP1OD006849
6 · The paper itself

Abstract

Cellular senescence is a terminal stress-activated program controlled by the p53 and p16(INK4a) tumor suppressor proteins. A striking feature of senescence is the senescence-associated secretory phenotype (SASP), a pro-inflammatory response linked to tumor promotion and aging. We have identified the transcription factor GATA4 as a senescence and SASP regulator. GATA4 is stabilized in cells undergoing senescence and is required for the SASP. Normally, GATA4 is degraded by p62-mediated selective autophagy, but this regulation is suppressed during senescence, thereby stabilizing GATA4. GATA4 in turn activates the transcription factor NF-κB to initiate the SASP and facilitate senescence. GATA4 activation depends on the DNA damage response regulators ATM and ATR, but not on p53 or p16(INK4a). GATA4 accumulates in multiple tissues, including the aging brain, and could contribute to aging and its associated inflammation.

Indexed as

DNA DamageAdaptor Proteins, Signal TransducingAgingAnimalsAtaxia Telangiectasia Mutated ProteinsAutophagyBrainCell CycleCells, CulturedCellular SenescenceCyclin-Dependent Kinase Inhibitor p16FibroblastsGATA4 Transcription FactorGene Expression ProfilingHumansInflammationAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanCyclin-Dependent Kinase Inhibitor p16GATA4 protein, humanGATA4 Transcription FactorIL1A protein, humanInterleukin-1alphaMicroRNAsMIRN146 microRNA, humanNF-kappa BTRAF3IP2 protein, humanTumor Necrosis Factor Receptor-Associated Peptides and ProteinsTumor Suppressor Protein p53

Identifiers

PMID26404840
PMCPMC4942138
OpenAlexW1800944583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.